Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: An Italian case-control study

Stroke

Volumn 29, Issue 2, 1998, Pages 399-403

  Margaglione, Maurizio ^a   Seripa, Davide ^a   Gravina, Carolina ^a   Grandone, Elvira ^a   Vecchione, Gennaro ^a   Cappucci, Giuseppe ^a   Merla, Giuseppe ^a   Papa, Sara ^a   Postiglione, Alfredo ^b   Di Minno, Giovanni ^b   Fazio, Vito M ^c  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Apolipoprotein E; Risk factors; Stroke; Thrombosis

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; BRAIN ISCHEMIA; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; STROKE;

EID: 0031909692     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.2.399     Document Type: Article

References (43)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 1988;58:249-261.
3. Steinberg D. The cholesterol controversy is over: Why did it take so long? Circulation 1989;80:1070-1078.
4. De Witt SG. Cholesterol revisited. Molecule, medicine, and media. Arteriosclerosis. 1989;9:430-438.
5. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
6. Ridker PM, Hennekens CH. Hemostatic risk factors for coronary heart disease. Circulation. 1991;83:1098-1100.
7. Heller HF, Chinn S, Tunstall Pedoe HD, Rose G. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. BMJ. 1984;288:1409-1411.
8. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic disease. JAMA. 1987;257:2318-2324.
9. Davignon J. Apolipoprotein E polymorphism and atherosclerosis. In: Born GVR, Schwartz CJ, eds. New Horizons in Coronary Heart Disease. London, UK: Science Press Ltd; 1993:5.1-5.21.
10. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J Lipid Res. 1992;33: 447-454.
11. Paik Y-K, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM. Nucleotide sequence and structure of the human apolipoprotein E gene. Prof Natl Acad Sci U S A. 1985;82:3445-3449.
12. Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982;257:2518-2521.
13. Hixson JE, for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb. 1991;11:1237-1244.
14. Cattin L, Fisicaro M, Tonizzo M, Valenti M, Danek GM, Fonda M, Da Col PG, Casagrande S, Pincetti E, Bovenzi M, Baralle F. Polymorphism of the spoliprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler Thromb Vasc Biol. 1997;17: 91-94.
15. Utermann G, Hardewig A, Zimmer F. Apo E phenotypes in patients with myocardial infarction. Hum Genet. 1984;65:237-241.
16. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA. 1994;272:1666-1671.
17. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 1995;91: 265-269.
18. Pedro-Botet J, Sentì M, Nogues X, Rubiès-Prat J, Roquer J, D'Olhaberriague L, Olivé J. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 1992;23:1556-1562.
19. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermania J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke. 1993;24:661-664.
20. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 1996;16:1250-1255.
21. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella GF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD. Association of apolipoprotein e4 allele with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
22. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, Jacomb PA. Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387-1390.
23. Coria F, Rubio I, Nuñez E, Sempere AP, Santa Engrazia N, Bayón C, Cuadrado N. Apolipoprotein E variants in ischemic stroke. Stroke. 1995; 26:2375-2376. Letter.
24. Kuusisto J, Mikkänen L, Kervinen K, Kesäniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 1995;15:1280-1286.
25. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, Winblad B, Viitanen N. Apolipoprotein E polymorphism and stroke in a population aged 75 years or more. Stroke. 1996;27:1310-1315.
26. Margaglione M, Di Minno G, Grandone E, Celentano E, Vecchione G, Cappucci G, Grilli M, Mancini FP, Postiglione A, Panico S, Mancini M. Plasma lipoprotein(a) levels in subjects attending a metabolic ward: discrimination between individuals with and without a history of ischemic stroke. Arterioscler Thromb Vasc Biol. 1996;16:120-128.
27. Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, Giordano M, Grilli M, Simone P, Fusilli S, Panico S, Mancini M. Raised plasma fibrinogen concentrations in subjects attending a metabolic ward: relation to family history and vascular risk factors. Thromb Haemoss. 1995;73:579-583.
28. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
29. Norusis MJ. SPSS/PC + V2.0 Base Manual. Chicago, Ill: SPSS Inc; 1988.
30. Slooter AJC, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Bretel MMB, Van Broeckhoven C, Tatemichi TK, Tycho B, Hofman A, Mayeux R. Apolipoprotein E ∈4 and the risk of dementia with stroke: a population-based investigation. JAMA. 1997;277:818-821.
31. Zeller K, Siostrzoneck P, Lang W, Gossinger H, Oder W, Ciciyasvilli H, Kolleger H, Mosslacher H, Deeke L. Different risk factor profiles in young and elderly stroke patients with special reference to cardiac disorders. J Clin Epidemiol. 1991;12:1383-1389.
32. Saunders AM, Roses AD. Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke. 1993;24:1416. Letter.
33. Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco L, Piacentini S, Amaducci L.Apo E allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 1994;177:100-102.
34. Corbo BM, Scacchi R, Mureddu L, Mulas G, Alfano G. Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique: comparison with frequency data of other European populations. Ann Hum Genet. 1995;59:197-209.
35. Brisoni GB, Bianchetti A, Trabucchi M, Govoni S. Diagnostic usefulness of apolipoprotein E ∈4 in the diagnosis of dementias. J Neurol Neurosurg Psychiatry. 1996;60:699-700. Letter.
36. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
37. Tiret L, de Knijff P, Menzel H-J, Ehnholm C, Nicaud V, Havekes LM, for the EARS Group. Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations. Arterioscler Thromb. 1994;14:1617-1624.
38. WHO MONICA Project. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project: an ecological study of 18 populations. Stroke. 1997;28:1367-1374.
39. Ricci S, Celani MG, Guercini G, Rucireta P, Vitali R, La Rosa F, Duca E, Ferraguzzi R, Paolotti M, Seppoloni D, Caputo N, Chiurulla C, Scaroni R, Signorini E. First-year results of a community-based study of stroke incidence in Umbria, Italy. Stroke. 1989;20:853-857.
40. D'Alessandro G, Di Giovanni M, Roveyaz L, Iannizzi L, Pesenti Compagnoni M, Blanc S, Bottacchi E. Incidence and prognosis of stroke in the Valle d'Aosta, Italy: first-year results of a community-based study. Stroke. 1992;23:1712-1715.
41. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342-344.
42. Wang XL, McCredie RM, Wilcken DEL. Polymorphism of the Apoli∈ poprotein E gene and severity of coronary heart disease defined by angiography. Arterioscler Thromb Vasc Biol. 1995;15:1030-1034.
43. Schächter F, Faure-Delanef L, Guenot F, Rouger H, Froguel R, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the Apo E and ACE loci. Nat Genet. 1994;6:29-32.